Title 21 — FOOD AND DRUGS

• § 16— Introduction into, or sale in, State or Territory or District of Columbia of dairy or food products falsely labeled or branded
• § 17— Penalty for sale or introduction of falsely labeled dairy or food products; venue
• § 18— Suspension of importation of adulterated articles
• § 20— Apples in interstate commerce; standard grades
• § 21— Branding grades on barrels of apples
• § 22— Barrels misbranded
• § 23— Penalties
• § 25— Oleomargarine, butterine, or imitation butter or cheese transported into a State subject to its police powers
• § 61— Definitions
• § 62— Manufacture, shipment, or delivery for shipment in interstate or foreign commerce prohibited
• § 63— Penalties; acts of agents deemed acts of principals
• § 64— Regulations for enforcement
• § 101— Suspension of importation of all animals
• § 113a— Establishment of research laboratories for foot-and-mouth disease and other animal diseases; research contracts; employment of technicians and scientists; appropriations
• § 114i— Pseudorabies eradication
• § 136— Additional inspection services
• § 136a— Collection of fees for inspection services
• § 141— Prohibition of importation without permit
• § 142— Milk or cream when unfit for importation
• § 143— Inspection; certified statement in lieu thereof; waiver of requirements of section 142; regulations; suspension and revocation of permits
• § 144— Unlawful receiving of imported milk or cream
• § 145— Penalties
• § 146— Authorization of appropriations
• § 147— Repeal of inconsistent laws
• § 148— Powers of State with respect to milk or cream lawfully imported
• § 149— Definitions
• § 151— Preparation and sale of worthless or harmful products for domestic animals prohibited; preparation to be in compliance with rules at licensed establishments
• § 152— Importation regulated and prohibited
• § 153— Inspection of imports; denial of entry and destruction
• § 154— Regulations for preparation and sale; licenses
• § 154a— Special licenses for special circumstances; expedited procedure; conditions; exemptions; criteria
• § 155— Permits for importation
• § 156— Licenses conditioned on permitting inspection; suspension of licenses
• § 157— Inspection
• § 158— Offenses; punishment
• § 159— Enforcement; penalties applicable; Congressional findings
• § 201— Doing business without a license unlawful; employment of Chinese subjects
• § 202— Certain classes of persons and corporations excepted; insecticides
• § 203— Application for license; requirements; qualifications for license
• § 204— Issuance of license
• § 205— Display of license in pharmacy
• § 206— Revocation of license
• § 207— Restrictions on sales; written orders or prescriptions
• § 208— Certain preparations and sales excepted
• § 209— Poisons; book entry of sale; labels
• § 210— Pharmacist; unauthorized use of title
• § 211— Preservation of originals of prescriptions compounded and copies thereof; inspection of prescriptions by consular officers; marking containers of drugs
• § 212— Offenses; punishment; duty to enforce provisions
• § 213— Fraudulent representations to evade or defeat restrictions
• § 214— Previous laws unaffected
• § 215— “Consul” defined
• § 301— Short title
• § 321— Definitions; generally
• § 321a— “Butter” defined
• § 321b— “Package” defined
• § 321c— Nonfat dry milk; “milk” defined
• § 321d— Market names for catfish and ginseng
• § 331— Prohibited acts
• § 332— Injunction proceedings
• § 333— Penalties
• § 334— Seizure
• § 335— Hearing before report of criminal violation
• § 335a— Debarment, temporary denial of approval, and suspension
• § 335b— Civil penalties
• § 335c— Authority to withdraw approval of abbreviated drug applications
• § 336— Report of minor violations
• § 337— Proceedings in name of United States; provision as to subpoenas
• § 337a— Extraterritorial jurisdiction
• § 341— Definitions and standards for food
• § 342— Adulterated food
• § 343— Misbranded food
• § 343–1— National uniform nutrition labeling
• § 343–2— Dietary supplement labeling exemptions
• § 343–3— Disclosure
• § 344— Emergency permit control
• § 345— Regulations making exemptions
• § 346— Tolerances for poisonous or deleterious substances in food; regulations
• § 346a— Tolerances and exemptions for pesticide chemical residues
• § 346b— Authorization of appropriations
• § 347— Intrastate sales of colored oleomargarine
• § 347a— Congressional declaration of policy regarding oleomargarine sales
• § 347b— Contravention of State laws
• § 348— Food additives
• § 349— Bottled drinking water standards; publication in Federal Register
• § 350— Vitamins and minerals
• § 350a— Infant formulas
• § 350a–1— Protecting infants and improving formula supply
• § 350b— New dietary ingredients
• § 350c— Maintenance and inspection of records
• § 350d— Registration of food facilities
• § 350e— Sanitary transportation practices
• § 350f— Reportable food registry
• § 350g— Hazard analysis and risk-based preventive controls
• § 350h— Standards for produce safety
• § 350i— Protection against intentional adulteration
• § 350j— Targeting of inspection resources for domestic facilities, foreign facilities, and ports of entry; annual report
• § 350k— Laboratory accreditation for analyses of foods
• § 350l— Mandatory recall authority
• § 350l–1— Annual report to Congress
• § 350m— Requirements for critical food
• § 351— Adulterated drugs and devices
• § 352— Misbranded drugs and devices
• § 353— Exemptions and consideration for certain drugs, devices, and biological products
• § 353a— Pharmacy compounding
• § 353a–1— Enhanced communication
• § 353b— Outsourcing facilities
• § 353c— Prereview of television advertisements
• § 353d— Process to update labeling for certain generic drugs
• § 354— Veterinary feed directive drugs
• § 355— New drugs
• § 355–1— Risk evaluation and mitigation strategies
• § 355–2— Actions for delays of generic drugs and biosimilar biological products
• § 355a— Pediatric studies of drugs
• § 355b— Adverse-event reporting
• § 355c— Research into pediatric uses for drugs and biological products
• § 355c–1— Report
• § 355d— Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
• § 355e— Pharmaceutical security
• § 355f— Extension of exclusivity period for new qualified infectious disease products
• § 355g— Utilizing real world evidence
• § 355h— Regulation of certain nonprescription drugs that are marketed without an approved drug application
• § 356— Expedited approval of drugs for serious or life-threatening diseases or conditions
• § 356–1— Accelerated approval of priority countermeasures
• § 356–2— Accelerated approval Council
• § 356a— Manufacturing changes
• § 356b— Reports of postmarketing studies
• § 356c— Discontinuance or interruption in the production of life-saving drugs
• § 356c–1— Annual reporting on drug shortages
• § 356d— Coordination; task force and strategic plan
• § 356e— Drug shortage list
• § 356f— Hospital repackaging of drugs in shortage
• § 356g— Standards for regenerative medicine and regenerative advanced therapies
• § 356h— Competitive generic therapies
• § 356i— Prompt reports of marketing status
• § 356j— Discontinuance or interruption in the production of medical devices
• § 356k— Platform technologies
• § 356l— Advanced manufacturing technologies designation program
• § 357— Qualification of drug development tools
• § 358— Authority to designate official names
• § 359— Nonapplicability of subchapter to cosmetics
• § 360— Registration of producers of drugs or devices
• § 360a— Clinical trial guidance for antibiotic drugs
• § 360a–1— Clinical trials
• § 360a–2— Susceptibility test interpretive criteria for microorganisms
• § 360aa— Recommendations for investigations of drugs for rare diseases or conditions
• § 360b— New animal drugs
• § 360b–1— Priority zoonotic animal drugs
• § 360bb— Designation of drugs for rare diseases or conditions
• § 360bbb— Expanded access to unapproved therapies and diagnostics
• § 360bbb–0— Expanded access policy required for investigational drugs
• § 360bbb–0a— Investigational drugs for use by eligible patients
• § 360bbb–1— Dispute resolution
• § 360bbb–2— Classification of products
• § 360bbb–3— Authorization for medical products for use in emergencies
• § 360bbb–3a— Emergency use of medical products
• § 360bbb–3b— Products held for emergency use
• § 360bbb–3c— Expedited development and review of medical products for emergency uses
• § 360bbb–4— Countermeasure development, review, and technical assistance
• § 360bbb–4a— Priority review to encourage treatments for agents that present national security threats
• § 360bbb–4b— Medical countermeasure master files
• § 360bbb–5— Critical Path Public-Private Partnerships
• § 360bbb–5a— Emerging technology program
• § 360bbb–6— Risk communication
• § 360bbb–7— Notification
• § 360bbb–8— Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments
• § 360bbb–8a— Optimizing global clinical trials
• § 360bbb–8b— Use of clinical investigation data from outside the United States
• § 360bbb–8c— Patient participation in medical product discussion
• § 360bbb–8d— Notification, nondistribution, and recall of controlled substances
• § 360c— Classification of devices intended for human use
• § 360c–1— Reporting
• § 360cc— Protection for drugs for rare diseases or conditions
• § 360ccc— Conditional approval of new animal drugs for minor use and minor species and certain new animal drugs
• § 360ccc–1— Index of legally marketed unapproved new animal drugs for minor species
• § 360ccc–2— Designated new animal drugs for minor use or minor species
• § 360d— Performance standards
• § 360dd— Open protocols for investigations of drugs for rare diseases or conditions
• § 360ddd— Definitions
• § 360ddd–1— Regulation of medical gases
• § 360ddd–2— Inapplicability of drug fees to designated medical gases
• § 360e— Premarket approval
• § 360e–1— Pediatric uses of devices
• § 360e–3— Breakthrough devices
• § 360e–4— Predetermined change control plans for devices
• § 360ee— Grants and contracts for development of drugs for rare diseases and conditions
• § 360ee–1— FDA rare neurodegenerative disease grant program
• § 360eee— Definitions
• § 360eee–1— Requirements
• § 360eee–2— National standards for prescription drug wholesale distributors
• § 360eee–3— National standards for third-party logistics providers
• § 360eee–4— Uniform national policy
• § 360f— Banned devices
• § 360ff— Priority review to encourage treatments for rare pediatric diseases
• § 360ff–1— Targeted drugs for rare diseases
• § 360fff— Definitions
• § 360fff–1— Submission of requests
• § 360fff–2— Eligibility determinations; data submission; filing
• § 360fff–3— GRASE determination
• § 360fff–4— Guidance; other provisions
• § 360fff–6— Non-sunscreen time and extent applications
• § 360fff–7— Report
• § 360fff–8— Sunset
• § 360g— Judicial review
• § 360g–1— Agency documentation and review of significant decisions regarding devices
• § 360g–2— Third party data transparency
• § 360h— Notification and other remedies
• § 360h–1— Program to improve the device recall system
• § 360hh— Definitions
• § 360i— Records and reports on devices
• § 360ii— Program of control
• § 360j— General provisions respecting control of devices intended for human use
• § 360jj— Studies by Secretary
• § 360k— State and local requirements respecting devices
• § 360kk— Performance standards for electronic products
• § 360l— Postmarket surveillance
• § 360ll— Notification of defects in and repair or replacement of electronic products
• § 360m— Accredited persons
• § 360mm— Imports
• § 360n— Priority review to encourage treatments for tropical diseases
• § 360n–1— Priority review for qualified infectious disease products
• § 360n–2— Ensuring cybersecurity of devices
• § 360nn— Inspection, records, and reports
• § 360oo— Prohibited acts
• § 360pp— Enforcement
• § 360rr— Federal-State cooperation
• § 360ss— State standards
• § 361— Adulterated cosmetics
• § 362— Misbranded cosmetics
• § 363— Regulations making exemptions
• § 364— Definitions
• § 364a— Adverse events
• § 364b— Good manufacturing practice
• § 364c— Registration and product listing
• § 364d— Safety substantiation
• § 364e— Labeling
• § 364f— Records
• § 364g— Mandatory recall authority
• § 364h— Small businesses
• § 364i— Exemption for certain products and facilities
• § 364j— Preemption
• § 371— Regulations and hearings
• § 372— Examinations and investigations
• § 373— Records
• § 374— Inspection
• § 374a— Inspections relating to food allergens
• § 375— Publicity
• § 376— Examination of sea food on request of packer; marking food with results; fees; penalties
• § 377— Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests
• § 378— Advertising of foods
• § 379— Confidential information
• § 379a— Presumption of existence of jurisdiction
• § 379aa— Serious adverse event reporting for nonprescription drugs
• § 379aa–1— Serious adverse event reporting for dietary supplements
• § 379b— Consolidated administrative and laboratory facility
• § 379d— Automation of Food and Drug Administration
• § 379d–1— Conflicts of interest
• § 379d–2— Policy on the review and clearance of scientific articles published by FDA employees
• § 379d–3— Streamlined hiring authority
• § 379d–3a— Hiring authority for scientific, technical, and professional personnel
• § 379d–3b— Strategic Workforce Plan and report
• § 379d–4— Reporting requirements
• § 379d–5— Guidance document regarding product promotion using the Internet
• § 379dd— Establishment and functions of the Foundation
• § 379dd–1— Location of Foundation
• § 379dd–2— Activities of the Food and Drug Administration
• § 379e— Listing and certification of color additives for foods, drugs, devices, and cosmetics
• § 379f— Recovery and retention of fees for freedom of information requests
• § 379g— Definitions
• § 379h— Authority to assess and use drug fees
• § 379h–1— Fees relating to advisory review of prescription-drug television advertising
• § 379h–2— Reauthorization; reporting requirements
• § 379i— Definitions
• § 379j— Authority to assess and use device fees
• § 379j–1— Reauthorization; reporting requirements
• § 379j–11— Definitions
• § 379j–12— Authority to assess and use animal drug fees
• § 379j–13— Reauthorization; reporting requirements
• § 379j–21— Authority to assess and use generic new animal drug fees
• § 379j–22— Reauthorization; reporting requirements
• § 379j–31— Authority to collect and use fees
• § 379j–41— Definitions
• § 379j–42— Authority to assess and use human generic drug fees
• § 379j–43— Reauthorization; reporting requirements
• § 379j–51— Definitions
• § 379j–52— Authority to assess and use biosimilar biological product fees
• § 379j–53— Reauthorization; reporting requirements
• § 379j–61— Definitions
• § 379j–62— Authority to assess and use outsourcing facility fees
• § 379j–71— Definitions
• § 379j–72— Authority to assess and use OTC monograph fees
• § 379j–73— Reauthorization; reporting requirements
• § 379k— Information system
• § 379k–1— Electronic format for submissions
• § 379l— Education
• § 379o— Environmental impact
• § 379r— National uniformity for nonprescription drugs
• § 379s— Preemption for labeling or packaging of cosmetics
• § 379v— Safety report disclaimers
• § 381— Imports and exports
• § 382— Exports of certain unapproved products
• § 383— Office of International Relations
• § 384— Importation of prescription drugs
• § 384a— Foreign supplier verification program
• § 384b— Voluntary qualified importer program
• § 384c— Inspection of foreign food facilities
• § 384d— Accreditation of third-party auditors
• § 384e— Recognition of foreign government inspections
• § 384f— Strengthening FDA and CBP coordination and capacity
• § 384g— Restricting entrance of illicit drugs
• § 387— Definitions
• § 387a— FDA authority over tobacco products
• § 387a–1— Final rule
• § 387b— Adulterated tobacco products
• § 387c— Misbranded tobacco products
• § 387d— Submission of health information to the Secretary
• § 387e— Annual registration
• § 387f— General provisions respecting control of tobacco products
• § 387f–1— Enforcement action plan for advertising and promotion restrictions
• § 387g— Tobacco product standards
• § 387h— Notification and other remedies
• § 387i— Records and reports on tobacco products
• § 387j— Application for review of certain tobacco products
• § 387k— Modified risk tobacco products
• § 387l— Judicial review
• § 387m— Equal treatment of retail outlets
• § 387n— Jurisdiction of and coordination with the Federal Trade Commission
• § 387o— Regulation requirement
• § 387p— Preservation of State and local authority
• § 387q— Tobacco Products Scientific Advisory Committee
• § 387r— Drug products used to treat tobacco dependence
• § 387s— User fees
• § 387t— Labeling, recordkeeping, records inspection
• § 387u— Studies of progress and effectiveness
• § 387v— Reporting on tobacco regulation activities
• § 391— Separability clause
• § 392— Exemption of meats and meat food products
• § 393— Food and Drug Administration
• § 393a— Office of Pediatric Therapeutics
• § 394— Scientific review groups
• § 395— Loan repayment program
• § 396— Practice of medicine
• § 397— Contracts for expert review
• § 398— Notices to States regarding imported food
• § 399— Grants to enhance food safety
• § 399a— Office of the Chief Scientist
• § 399b— Office of Women’s Health
• § 399c— Improving the training of State, local, territorial, and tribal food safety officials
• § 399d— Employee protections
• § 399e— Nanotechnology
• § 399f— Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups
• § 399g— Food and Drug Administration Intercenter Institutes
• § 399h— National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing
• § 399i— Food and Drug Administration Working Capital Fund
• § 399j— Abraham Accords Office
• § 451— Congressional statement of findings
• § 452— Congressional declaration of policy
• § 453— Definitions
• § 454— Federal and State cooperation in development and administration of State poultry product inspection programs
• § 455— Inspection in official establishments
• § 456— Operation of premises, facilities and equipment
• § 457— Labeling and container standards
• § 458— Prohibited acts
• § 459— Compliance by all establishments
• § 460— Miscellaneous activities subject to regulation
• § 461— Offenses and punishment
• § 462— Reporting of violations; notice; opportunity to present views
• § 463— Rules and regulations
• § 464— Exemptions
• § 465— Limitations upon entry of poultry products and other materials into official establishments
• § 466— Imports
• § 467— Inspection services
• § 467a— Administrative detention; duration; pending judicial proceedings; notification of government authorities; release; removal of official marks
• § 467b— Seizure and condemnation
• § 467c— Federal court jurisdiction of enforcement and injunction proceedings and other kinds of cases; limitations; United States as plaintiff; subpenas
• § 467d— Administration and enforcement; applicability of penalty provisions; conduct of inquiries; power and jurisdiction of courts
• § 467e— Non-Federal jurisdiction of federally regulated matters; prohibition of additional or different requirements for establishments with inspection services and as to marking, labeling, packaging, and ingredients; recordkeeping and related requirements; concurrent jurisdiction over distribution for human food purposes of adulterated or misbranded and imported articles; other matters
• § 467f— Federal Food, Drug, and Cosmetic Act applications
• § 468— Cost of inspection; overtime
• § 469— Authorization of appropriations
• § 471— Safe Meat and Poultry Inspection Panel
• § 472— Interstate shipment of poultry inspected by Federal and State agencies for certain small establishments
• § 473— Grants for improvements to meat and poultry facilities to allow for interstate shipment
• § 601— Definitions
• § 602— Congressional statement of findings
• § 603— Examination of animals prior to slaughter; use of humane methods
• § 604— Post mortem examination of carcasses and marking or labeling; destruction of carcasses condemned; reinspection
• § 605— Examination of carcasses brought into slaughtering or packing establishments, and of meat food products issued from and returned thereto; conditions for entry
• § 606— Inspection and labeling of meat food products
• § 607— Labeling, marking, and container requirements
• § 608— Sanitary inspection and regulation of slaughtering and packing establishments; rejection of adulterated meat or meat food products
• § 609— Examination of animals and food products thereof, slaughtered and prepared during nighttime
• § 610— Prohibited acts
• § 611— Devices, marks, labels, and certificates; simulations
• § 612— Notification
• § 613— Plans and reassessments
• § 615— Inspection of carcasses, meat of which is intended for export
• § 616— Inspectors of carcasses, etc., meat of which is intended for export; certificates of condition
• § 617— Clearance prohibited to vessel carrying meat for export without inspector’s certificate
• § 618— Delivery of inspectors’ certificates, and of copies
• § 619— Marking, labeling, or other identification to show kinds of animals from which derived; separate establishments for preparation and slaughtering activities
• § 620— Imports
• § 621— Inspectors to make examinations provided for; appointment; duties; regulations
• § 622— Bribery of or gifts to inspectors or other officers and acceptance of gifts
• § 623— Exemptions from inspection requirements
• § 624— Storage and handling regulations; violations; exemption of establishments subject to non-Federal jurisdiction
• § 625— Inapplicability of certain requirements to catfish
• § 626— Purchase of tags, labels, stamps, and certificates
• § 641— Prohibition of subchapter I inspection of articles not intended for use as human food; de­naturation or other identification prior to distribution in commerce; inedible articles
• § 642— Recordkeeping requirements
• § 643— Registration of business, name of person, and trade names
• § 644— Regulation of transactions, transportation, or importation of 4–D animals to prevent use as human food
• § 645— Federal provisions applicable to State or Territorial business transactions of a local nature and not subject to local authority
• § 661— Federal and State cooperation
• § 671— Inspection services; refusal or withdrawal; hearing; business unfitness based upon certain convictions; other provisions for withdrawal of services unaffected; responsible connection with business; finality of Secretary’s actions; judicial review; record
• § 672— Administrative detention; duration; pending judicial proceedings; notification of governmental authorities; release
• § 673— Seizure and condemnation
• § 674— Federal court jurisdiction of enforcement and injunction proceedings and other kinds of cases; limitations of section 607(e) of this title
• § 675— Assaulting, resisting, or impeding certain persons; murder; protection of such persons
• § 676— Violations
• § 677— Other Federal laws applicable for administration and enforcement of chapter; location of inquiries; jurisdiction of Federal courts
• § 678— Non-Federal jurisdiction of federally regulated matters; prohibition of additional or different requirements for establishments with inspection services and as to marking, labeling, packaging, and ingredients; recordkeeping and related requirements; concurrent jurisdiction over distribution for human food purposes of adulterated or misbranded and imported articles; other matters
• § 679— Application of Federal Food, Drug, and Cosmetic Act
• § 679a— Safe Meat and Poultry Inspection Panel
• § 679b— Pasteurization of meat and poultry
• § 679c— Expansion of Food Safety Inspection Service activities
• § 680— Authorization of appropriations
• § 683— Interstate shipment of meat inspected by Federal and State agencies for certain small establishments
• § 692— Inspection extended to reindeer
• § 693— Inspection of dairy products for export
• § 694— Authorization of appropriations
• § 695— Payment of cost of meat-inspection service; exception
• § 801— Congressional findings and declarations: controlled substances
• § 801a— Congressional findings and declarations: psychotropic substances
• § 802— Definitions
• § 811— Authority and criteria for classification of substances
• § 812— Schedules of controlled substances
• § 813— Treatment of controlled substance analogues
• § 814— Removal of exemption of certain drugs
• § 821— Rules and regulations
• § 822— Persons required to register
• § 822a— Prescription drug take back expansion
• § 823— Registration requirements
• § 824— Denial, revocation, or suspension of registration
• § 825— Labeling and packaging
• § 826— Production quotas for controlled substances
• § 826a— Attorney General report on drug shortages
• § 827— Records and reports of registrants
• § 828— Order forms
• § 829— Prescriptions
• § 829a— Delivery of a controlled substance by a pharmacy to an administering practitioner
• § 830— Regulation of listed chemicals and certain machines
• § 831— Additional requirements relating to online pharmacies and telemedicine
• § 832— Suspicious orders
• § 841— Prohibited acts A
• § 842— Prohibited acts B
• § 843— Prohibited acts C
• § 844— Penalties for simple possession
• § 844a— Civil penalty for possession of small amounts of certain controlled substances
• § 846— Attempt and conspiracy
• § 847— Additional penalties
• § 848— Continuing criminal enterprise
• § 849— Transportation safety offenses
• § 850— Information for sentencing
• § 851— Proceedings to establish prior convictions
• § 852— Application of treaties and other international agreements
• § 853— Criminal forfeitures
• § 854— Investment of illicit drug profits
• § 855— Alternative fine
• § 856— Maintaining drug-involved premises
• § 858— Endangering human life while illegally manufacturing controlled substance
• § 859— Distribution to persons under age twenty-one
• § 860— Distribution or manufacturing in or near schools and colleges
• § 860a— Consecutive sentence for manufacturing or distributing, or possessing with intent to manufacture or distribute, methamphetamine on premises where children are present or reside
• § 861— Employment or use of persons under 18 years of age in drug operations
• § 862— Denial of Federal benefits to drug traffickers and possessors
• § 862a— Denial of assistance and benefits for certain drug-related convictions
• § 862b— Sanctioning for testing positive for controlled substances
• § 863— Drug paraphernalia
• § 864— Anhydrous ammonia
• § 864a— Grants to reduce production of methamphetamines from anhydrous ammonia
• § 865— Smuggling methamphetamine or methamphetamine precursor chemicals into the United States while using facilitated entry programs
• § 871— Attorney General
• § 871a— Semiannual reports to Congress
• § 872— Education and research programs of Attorney General
• § 872a— Public-private education program
• § 873— Cooperative arrangements
• § 874— Advisory committees
• § 875— Administrative hearings
• § 876— Subpenas
• § 877— Judicial review
• § 878— Powers of enforcement personnel
• § 879— Search warrants
• § 880— Administrative inspections and warrants
• § 881— Forfeitures
• § 882— Injunctions
• § 883— Enforcement proceedings
• § 884— Immunity and privilege
• § 885— Burden of proof; liabilities
• § 886— Payments and advances
• § 886a— Diversion Control Fee Account
• § 887— Coordination and consolidation of post-seizure administration
• § 889— Production control of controlled substances
• § 890— Review of Federal sales of chemicals usable to manufacture controlled substances
• § 901— Severability
• § 902— Savings provisions
• § 903— Application of State law
• § 904— Payment of tort claims
• § 951— Definitions
• § 952— Importation of controlled substances
• § 953— Exportation of controlled substances
• § 954— Transshipment and in-transit shipment of controlled substances
• § 955— Possession on board vessels, etc., arriving in or departing from United States
• § 956— Exemption authority
• § 957— Persons required to register
• § 958— Registration requirements
• § 959— Possession, manufacture, or distribution of controlled substance
• § 960— Prohibited acts A
• § 960a— Foreign terrorist organizations, terrorist persons and groups
• § 961— Prohibited acts B
• § 962— Second or subsequent offenses
• § 963— Attempt and conspiracy
• § 964— Additional penalties
• § 965— Applicability of part E of subchapter I
• § 966— Authority of Secretary of the Treasury
• § 967— Smuggling of controlled substances; investigations; oaths; subpenas; witnesses; evidence; production of records; territorial limits; fees and mileage of witnesses
• § 968— Service of subpena; proof of service
• § 969— Contempt proceedings
• § 970— Criminal forfeitures
• § 971— Notification, suspension of shipment, and penalties with respect to importation and exportation of listed chemicals
• § 1031— Congressional statement of findings
• § 1032— Congressional declaration of policy
• § 1033— Definitions
• § 1034— Inspection of egg products
• § 1035— Sanitary operating practices in official plants
• § 1036— Pasteurization and labeling of egg products at official plants
• § 1037— Prohibited acts
• § 1038— Cooperation with appropriate State and other governmental agencies; utilization of employees; reimbursement
• § 1039— Eggs and egg products not intended for use as human food; inspection; denaturing or otherwise identifying
• § 1040— Recordkeeping requirements; persons required to maintain records; scope of disclosure; access to records
• § 1041— Enforcement provisions
• § 1042— Reporting of violation to United States attorney for institution of criminal proceedings; procedure; presentation of views
• § 1043— Rules and regulations; administration and enforcement
• § 1044— Exemption of certain activities
• § 1045— Limitation on entry of eggs and egg products and other materials into official plants
• § 1046— Imports
• § 1047— Refusal or withdrawal of inspection services; hearing; grounds; person deemed to have responsible connection with business; finality of order of Secretary; judicial review; other provisions for refusal of services unaffected
• § 1048— Administrative detention of violative articles; duration; release; removal of official marks
• § 1049— Seizure and condemnation proceedings
• § 1050— Jurisdiction of district courts; United States as plaintiff in enforcement and restraining proceedings; subpenas for witnesses
• § 1051— Other Federal laws applicable for administration and enforcement of chapter; prosecution of inquiries; exercise of jurisdiction
• § 1052— State or local regulation
• § 1053— Inspection and administration costs
• § 1054— Annual report to Congressional committees
• § 1055— Authorization of appropriations
• § 1056— Separability
• § 1101— Congressional findings
• § 1102— Congressional declaration of national policy
• § 1115— Notice relating to the control of dangerous drugs
• § 1171— Drug abuse prevention function appropriations
• § 1177— Special project grants and contracts
• § 1178— Records and audit
• § 1179— National Drug Abuse Training Center
• § 1181— Contract authority
• § 1401— Pesticide monitoring and enforcement information
• § 1402— Foreign pesticide information
• § 1403— Pesticide analytical methods
• § 1505a— Annual report on development and deployment of narcotics detection technologies
• § 1521— Findings
• § 1522— Purposes
• § 1523— Definitions
• § 1524— Authorization of appropriations
• § 1531— Establishment of drug-free communities support program
• § 1532— Program authorization
• § 1533— Information collection and dissemination with respect to grant recipients
• § 1534— Technical assistance and training
• § 1535— Supplemental grants for coalition mentoring activities
• § 1536— Community-based coalition enhancement grants to address local drug crises
• § 1601— Findings
• § 1602— Definitions
• § 1603— General requirements; applicability; preemption
• § 1604— Liability of biomaterials suppliers
• § 1605— Procedures for dismissal of civil actions against biomaterials suppliers
• § 1606— Subsequent impleader of dismissed biomaterials supplier
• § 1701— Definitions
• § 1702— Office of National Drug Control Policy
• § 1703— Appointment and duties of Director and Deputy Directors
• § 1704— Coordination with National Drug Control Program agencies in demand reduction, supply reduction, and State and local affairs
• § 1705— Development, submission, implementation, and assessment of National Drug Control Strategy
• § 1706— High Intensity Drug Trafficking Areas Program
• § 1708— Emerging Threats Committee, plan, and media campaign
• § 1710— Drug Interdiction Coordinator and Committee
• § 1710a— Requirement for disclosure of Federal sponsorship of all Federal advertising or other communication materials
• § 1711— Authorization of appropriations
• § 1713— Authorization of use of environmentally-approved herbicides to eliminate illicit narcotics crops
• § 1714— Awards for demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through the use of drug testing and sanctions
• § 1715— GAO audit
• § 1901— Findings and policy
• § 1902— Purpose
• § 1903— Public identification of significant foreign narcotics traffickers and required reports
• § 1904— Blocking assets and prohibiting transactions
• § 1905— Authorities
• § 1906— Enforcement
• § 1907— Definitions
• § 1908— Judicial Review Commission on Foreign Asset Control
• § 2001— Designation of United States Anti-Doping Agency
• § 2002— Records, audit, and report
• § 2003— Authorization of appropriations
• § 2004— Information sharing
• § 2011— Definitions
• § 2012— Establishment of clearinghouse and advisory council
• § 2013— NMIC requirements and review
• § 2014— Authorization of appropriations
• § 2101— Findings
• § 2102— Ensuring the safety of pet food
• § 2103— Ensuring efficient and effective communications during a recall
• § 2104— State and Federal cooperation
• § 2105— Enhanced aquaculture and seafood inspection
• § 2106— Consultation regarding genetically engineered seafood products
• § 2107— Sense of Congress
• § 2108— Annual report to Congress
• § 2109— Publication of annual reports
• § 2110— Rule of construction
• § 2201— Performance standards
• § 2202— National Agriculture and Food Defense Strategy
• § 2203— Food and Agriculture Coordinating Councils
• § 2204— Building domestic capacity
• § 2205— Food allergy and anaphylaxis management
• § 2206— Alcohol-related facilities
• § 2221— Food emergency response network
• § 2222— Integrated consortium of laboratory networks
• § 2223— Enhancing tracking and tracing of food and recordkeeping
• § 2224— Surveillance
• § 2225— Decontamination and disposal standards and plans
• § 2241— Inspection by the Secretary of Commerce
• § 2242— Foreign offices of the Food and Drug Administration
• § 2243— Smuggled food
• § 2251— Jurisdiction; authorities
• § 2252— Compliance with international agreements
• § 2301— Sense of Congress
• § 2302— Definitions
• § 2311— Identification of foreign opioid traffickers
• § 2312— Imposition of sanctions
• § 2313— Description of sanctions
• § 2313a— Designation of transactions of sanctioned persons as of primary money laundering concern
• § 2314— Waivers
• § 2315— Procedures for judicial review of classified information
• § 2316— Briefings on implementation
• § 2331— Director of National Intelligence program on use of intelligence resources in efforts to sanction foreign opioid traffickers
• § 2332— Authorization of appropriations
• § 2333— Regulatory authority
• § 2334— Termination
• § 2335— Exception relating to importation of goods
• § 2341— Definitions
• § 2351— Finding; policy
• § 2352— Use of national emergency authorities; reporting
• § 2353— Imposition of sanctions with respect to fentanyl trafficking by transnational criminal organizations
• § 2354— Penalties; waivers; exceptions
• § 2355— Treatment of forfeited property of transnational criminal organizations
• § 2361— Treatment of transnational criminal organizations in suspicious transactions reports of the Financial Crimes Enforcement Network
• § 2371— Exception relating to importation of goods
• § 2401— Definitions
• § 2402— Major international doping fraud conspiracies
• § 2403— Criminal penalties and statute of limitations
• § 2404— Coordination and sharing of information with USADA